INITIAL FILING

Company

LIGAND PHARMACEUTICALS INC

Filed

September 23, 2005

Accession Number

0000899140-05-000884

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →